Graf Akcie VIVO (Meridian Bioscience Inc.). Diskuze k akciím VIVO. Aktuální informace VIVO.

Základní informace o společnosti Meridian Bioscience Inc. (Akcie VIVO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 799.01M
Hodnota podniku (EV) 832.32M
Tržby 305.845M
EBITDA 110.447M
Zisk 71.243M
Růst v tržbách Q/Q -25.10 %
Růst v tržbách Y/Y 27.24 %
P/E (Cena vůči ziskům) 11.18
Forward P/E 0.17
EV/Sales 2.72
EV/EBITDA 7.54
EV/EBIT 9.01
PEG 1.41
Price/Sales 2.62
P/FCF 15.59
Price/Book 3.24
Účetní hodnota na akcii 5.69
Hotovost na akcii 1.23
FCF vůči ceně 6.41 %
Počet zaměstnanců 750
Tržba na zaměstnance 407.793k
Profit margin 18.21 %
Operating margin 30.74 %
Gross margin 61.60 %
EBIT margin 30.22 %
EBITDA margin 36.11 %
EPS - Zisk na akcii 1.65
EPS - Kvartální růst -60.00 %
EPS - Očekávaný růst příští rok 120.00 %
Return on assets 16.62 %
Return on equity 24.61 %
ROIC 16.95 %
ROCE 22.55 %
Dluhy/Equity 0.64
Čistý dluh/EBITDA 0.44
Current ratio 5.31
Quick Ratio 3.36
Volatilita 3.45
Beta 0.80
RSI 40.49
Cílová cena analytiků 26
Známka akcie (dle analytiků) 1.00
Insider ownership 0.54 %
Institutional ownership 98.08 %
Počet akcií 43.354M
Procento shortovaných akcií 10.75 %
Short ratio 11.67 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk 0.00 %
Obchodovaná od 1986
Země United States

Finanční výsledky akcie VIVO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$253.667$201.014$213.571$200.771$196.082$194.83
Cost Of Goods Sold$97.419$82.286$82.538$76.479$68.87$72.948
Gross Profit$156.248$118.728$131.033$124.292$127.212$121.882
Research And Development Expenses$23.729$17.76$16.613$16.036$14.191$12.605
SG&A Expenses$70.831$62.039$69.785$63.484$59.485$53.217
Other Operating Income Or Expenses$0.323$-3.391$-4.345$-0.628$-1.481-
Operating Expenses$192.343$168.315$181.987$163.389$144.704$138.77
Operating Income$61.324$32.699$31.584$37.382$51.378$56.06
Total Non-Operating Income/Expense$-2.031$-1.142$-1.204$-0.953$-0.734$-0.997
Pre-Tax Income$59.293$31.557$30.38$36.429$50.644$55.063
Income Taxes$13.107$7.175$6.531$14.872$18.415$19.523
Income After Taxes$46.186$24.382$23.849$21.557$32.229$35.54
Other Income------
Income From Continuous Operations$46.186$24.382$23.849$21.557$32.229$35.54
Income From Discontinued Operations------
Net Income$46.186$24.382$23.849$21.557$32.229$35.54
EBITDA$74.891$42.663$40.272$53.1$59.096$62.669
EBIT$61.324$32.699$31.584$37.382$51.378$56.06
Basic Shares Outstanding434342424242
Shares Outstanding434343434242
Basic EPS$1.08$0.57$0.56$0.51$0.77$0.85
EPS - Earnings Per Share$1.07$0.57$0.56$0.51$0.76$0.85
# 2020 2019 2018 2017 2016 2015
Current Ratio3.08796.92175.75245.84945.61747.8304
Long-term Debt / Capital0.21750.28420.20390.22820.247-
Debt/Equity Ratio0.27790.39710.28610.32220.3506-
Gross Margin61.595759.064561.353461.907464.876962.5581
Operating Margin24.17516.26714.788518.619226.202328.7738
EBIT Margin24.17516.26714.788518.619226.202328.7738
EBITDA Margin29.523421.223918.856526.44830.138432.166
Pre-Tax Profit Margin23.374315.698914.224818.144625.82828.2621
Net Profit Margin18.207312.129511.166810.737116.436518.2415
Asset Turnover0.62590.61760.84960.80380.7781.063
Inventory Turnover Ratio1.59022.0771.96551.84321.52852.0367
Receiveable Turnover6.58675.47756.60476.89797.2357.421
Days Sales In Receivables55.414766.63655.263352.914550.449549.185
ROE - Return On Equity18.651312.767713.595512.711619.3621.426
Return On Tangible Equity91.919858.775924.418424.509143.182225.8298
ROA - Return On Assets11.39667.49119.48738.630512.787919.3909
ROI - Return On Investment14.59499.13910.82339.810614.577921.426
Book Value Per Share5.74964.4714.13724.01793.95353.9646
Operating Cash Flow Per Share0.26790.0296-0.15770.0934-0.1410.1061
Free Cash Flow Per Share0.26450.0549-0.15110.0829-0.15270.15